BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 67
- +17 vs. Q4 2025
- Shares held
- 57.4M
- +334.2K (+0.6%) vs. Q4 2025
- Total value
- $513.8M
- −$200.9M (−28.1%) vs. Q4 2025
- New holders
- 23
- 20 more added
- Sold out
- 6
- 11 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 4 | $36 | 0.00% | +4 | New |
| Royal Bank of Canada | 154 | $1.00K | 0.00% | +154 | New |
| Barclays PLC | 212 | $1.90K | 0.00% | +212 | New |
| Wells Fargo & Company | 300 | $2.69K | 0.00% | 00.0% | Unchanged |
| Accent Capital Management, LLC | 335 | $3.00K | 0.00% | +335 | New |
| Rockefeller Capital Management L.P. | 700 | $6.26K | 0.00% | 00.0% | Unchanged |
| Bellevue Group AG | 6,982 | $62.5K | 0.00% | +6,982 | New |
| Aquatic Capital Management LLC | 11,793 | $105.5K | 0.00% | +11,793 | New |
| Quadrature Capital Ltd | 13,351 | $119.5K | 0.00% | +429+3.3% | Added |
| Brevan Howard Capital Management LP | 14,248 | $127.5K | 0.00% | +14,248 | New |
| Diametric Capital, LP | 16,280 | $145.7K | 0.04% | +16,280 | New |
| Axq Capital, LP | 17,347 | $155.3K | 0.02% | +17,347 | New |
| Vanguard Global Advisers, LLC | 18,163 | $162.6K | 0.00% | +18,163 | New |
| Acadian Asset Management LLC | 29,148 | $260.0K | 0.00% | +29,148 | New |
| Manufacturers Life Insurance Company, The | 35,692 | $319.4K | 0.00% | −18,500−34.1% | Reduced |
| Squarepoint Ops LLC | 43,190 | $386.6K | 0.00% | +31,675+275.1% | Added |
| Morgan Stanley | 43,374 | $388.2K | 0.00% | +29,022+202.2% | Added |
| Avidity Partners Management LP | 43,853 | $392.5K | 0.08% | +43,853 | New |
| ExodusPoint Capital Management, LP | 48,122 | $430.7K | 0.00% | +48,122 | New |
| UBS Group AG | 50,450 | $451.5K | 0.00% | −42,919−46.0% | Reduced |
| Opaleye Management Inc. | 53,282 | $476.9K | 0.06% | +53,282 | New |
| TD Asset Management Inc | 57,572 | $515.3K | 0.00% | −59,578−50.9% | Reduced |
| XTX Topco Ltd | 59,743 | $534.7K | 0.01% | +31,110+108.7% | Added |
| Qube Research & Technologies Ltd | 71,925 | $643.7K | 0.00% | +35,973+100.1% | Added |
| HighVista Strategies LLC | 78,187 | $699.8K | 0.19% | −151,076−65.9% | Reduced |
| Boothbay Fund Management, LLC | 80,884 | $723.9K | 0.02% | +13,850+20.7% | Added |
| Toroso Investments, LLC | 82,172 | $735.4K | 0.00% | +82,172 | New |
| Tema ETFs LLC | 82,172 | $735.4K | 0.05% | +82,172 | New |
| BNP Paribas Arbitrage, SA | 90,819 | $812.8K | 0.00% | +64,347+243.1% | Added |
| Moore Capital Management, LP | 100,000 | $895.0K | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 101,900 | $912.0K | 0.00% | +27,600+37.1% | Added |
| Northern Trust Corp | 102,258 | $915.2K | 0.00% | +44,224+76.2% | Added |
| Woodline Partners LP | 103,707 | $928.2K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 110,000 | $984.5K | 0.01% | +110,000 | New |
| Sio Capital Management, LLC | 130,628 | $1.17M | 0.17% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 167,573 | $1.50M | 0.00% | +72,922+77.0% | Added |
| State Street Corp | 226,278 | $2.03M | 0.00% | +8,000+3.7% | Added |
| Granahan Investment Management Inc | 231,040 | $2.07M | 0.10% | +231,040 | New |
| FMR LLC | 240,300 | $2.15M | 0.00% | 00.0% | Unchanged |
| Schroder Investment Management Group | 249,161 | $2.16M | 0.00% | +249,161 | New |
| Vanguard Fiduciary Trust Co | 254,329 | $2.28M | 0.00% | +254,329 | New |
| Millennium Management LLC | 265,954 | $2.38M | 0.00% | +24,539+10.2% | Added |
| Ikarian Capital, LLC | 270,231 | $2.42M | 0.35% | +50,000+22.7% | Added |
| Casdin Capital, LLC | 282,312 | $2.53M | 0.19% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 290,806 | $2.60M | 0.00% | +11,760+4.2% | Added |
| Ensign Peak Advisors, Inc | 320,874 | $2.87M | 0.01% | +320,874 | New |
| Adage Capital Partners GP, L.L.C. | 400,000 | $3.58M | 0.01% | −1,000,000−71.4% | Reduced |
| Price T Rowe Associates Inc | 437,889 | $3.92M | 0.00% | −365,245−45.5% | Reduced |
| Eventide Asset Management, LLC | 541,181 | $4.70M | 0.08% | −541,181−50.0% | Reduced |
| Vanguard Capital Management LLC | 538,441 | $4.82M | 0.00% | +538,441 | New |
| Geode Capital Management, LLC | 579,234 | $5.19M | 0.00% | +17,247+3.1% | Added |
| Royce & Associates LP | 636,522 | $5.70M | 0.06% | +636,522 | New |
| Octagon Capital Advisors LP | 719,000 | $6.44M | 0.71% | −324,110−31.1% | Reduced |
| Paradigm Biocapital Advisors LP | 868,213 | $7.77M | 0.16% | −1,393,536−61.6% | Reduced |
| Aisling Capital Management LP | 1,018,018 | $9.11M | 1.91% | +453,393+80.3% | Added |
| Armistice Capital, LLC | 1,328,000 | $11.9M | 0.39% | +328,000+32.8% | Added |
| Laurion Capital Management LP | 1,922,656 | $17.2M | 1.61% | +457,718+31.2% | Added |
| BlackRock, Inc. | 2,088,297 | $18.7M | 0.00% | +3,460+0.2% | Added |
| Novo Holdings A/S | 2,185,923 | $19.6M | 1.59% | +224,606+11.5% | Added |
| Citadel Advisors LLC | 2,528,762 | $22.6M | 0.02% | −1,562−0.1% | Reduced |
| Enavate Sciences GP, LLC | 2,626,946 | $23.5M | 6.69% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,818,348 | $25.2M | 0.00% | −88,655−3.0% | Reduced |
| EcoR1 Capital, LLC | 2,823,126 | $25.3M | 1.08% | 00.0% | Unchanged |
| Alphabet Inc. | 2,823,126 | $25.3M | 0.63% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 3,289,661 | $29.4M | 18.05% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 4,885,446 | $43.7M | 0.52% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 17,878,594 | $160.0M | 8.07% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −226,248−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −86,517−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −23,584−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −8,585−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −3,990−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |